These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7537561)

  • 41. Anti-proliferative effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: use of poly (lysine/serine) copolymers or cationic lipopolyamines.
    Aoki Y; Kawa S; Karasawa Y; Horiuchi A; Kiyosawa K
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):702-5. PubMed ID: 9750959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3'-alkylamino oligodeoxynucleotides, 2'-O-methyl oligoribonucleotides, oligodeoxynucleoside methylphosphonates, and peptide nucleic acids.
    Gray GD; Basu S; Wickstrom E
    Biochem Pharmacol; 1997 May; 53(10):1465-76. PubMed ID: 9260874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.
    Krieg AM; Guga P; Stec W
    Oligonucleotides; 2003; 13(6):491-9. PubMed ID: 15025915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides.
    Rockwell P; O'Connor WJ; King K; Goldstein NI; Zhang LM; Stein CA
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6523-8. PubMed ID: 9177251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.
    Wang W; Chen HJ; Schwartz A; Cannon PJ; Stein CA; Rabbani LE
    J Clin Invest; 1996 Jul; 98(2):443-50. PubMed ID: 8755655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorothioate and normal oligodeoxyribonucleotides with 5'-linked acridine: characterization and preliminary kinetics of cellular uptake.
    Stein CA; Mori K; Loke SL; Subasinghe C; Shinozuka K; Cohen JS; Neckers LM
    Gene; 1988 Dec; 72(1-2):333-41. PubMed ID: 2854090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of the effects of antisense oligodeoxynucleotides to islet amyloid polypeptide mRNA on insulin release, content and expression.
    Kulkarni RN; Smith DM; Ghatei MA; Jones PM; Bloom SR
    J Endocrinol; 1996 Dec; 151(3):341-8. PubMed ID: 8994379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems.
    Summerton J; Stein D; Huang SB; Matthews P; Weller D; Partridge M
    Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):63-70. PubMed ID: 9149841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides.
    Vaughn JP; Stekler J; Demirdji S; Mills JK; Caruthers MH; Iglehart JD; Marks JR
    Nucleic Acids Res; 1996 Nov; 24(22):4558-64. PubMed ID: 8948649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.
    Beck GF; Irwin WJ; Nicklin PL; Akhtar S
    Pharm Res; 1996 Jul; 13(7):1028-37. PubMed ID: 8842040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced downregulation of the p75 nerve growth factor receptor by cholesteryl and bis-cholesteryl antisense oligonucleotides.
    Epa WR; Rong P; Bartlett PF; Coulson EJ; Barrett GL
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):489-98. PubMed ID: 9918113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides.
    Teasdale RM; Matson SJ; Fisher E; Krieg AM
    Antisense Res Dev; 1994; 4(4):295-7. PubMed ID: 7734945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of phage phi 29 assembly by antisense oligonucleotides targeting viral pRNA essential for DNA packaging.
    Zhang C; Garver K; Guo P
    Virology; 1995 Aug; 211(2):568-76. PubMed ID: 7645260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.
    Mishra M; Porter-Kelley JM; Singh PK; Bennett JR; Chaudhuri G
    Biochem Pharmacol; 2001 Sep; 62(5):569-80. PubMed ID: 11585054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors.
    Rubenstein M; Tsui P; Guinan P
    Med Hypotheses; 2005; 65(5):905-7. PubMed ID: 16023790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication.
    Diabata M; Enzinger EM; Monroe JE; Kilkuskie RE; Field AK; Mulder C
    Antiviral Res; 1996 Mar; 29(2-3):243-60. PubMed ID: 8739603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of troponin C production without affecting other muscle protein synthesis by the antisense oligodeoxynucleotide.
    Ojala J; Choudhury M; Bag J
    Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):31-8. PubMed ID: 9055036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liposomal delivery of oligodeoxynucleotides.
    Tari A; Khodadadian M; Ellerson D; Deisseroth A; Lopez-Berestein G
    Leuk Lymphoma; 1996 Mar; 21(1-2):93-7. PubMed ID: 8907275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bispecific antisense oligonucleotides have activity comparable to monospecifics in inhibiting expression of BCL-2 in LNCaP cells.
    Rubenstein M; Guinan P
    In Vivo; 2010; 24(4):489-93. PubMed ID: 20668314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.